发明名称 |
USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB |
摘要 |
The present application describes uses for and articles of manufacture including Pertuzumab a first in class HER2 dimerization inhibitor. In particular the application describes methods for extending progression free survival in a HER2 positive breast cancer patient population; combining two HER2 antibodies to treat HER2 positive cancer without increasing cardiac toxicity; treating early stage HER2 positive breast cancer; treating HER2 positive cancer by co administering a mixture of Pertuzumab and Trastuzumab from the same intravenous bag; treating HER2 positive metastatic gastric cancer; treating HER2 positive breast cancer with Pertuzumab Trastuzumab and Vinorelbine; treating HER2 positive breast cancer with Pertuzumab Trastuzumab and aromatase inhibitor; and treating low HER3 ovarian primary peritoneal or fallopian tube cancer. It also describes an article of manufacture comprising a vial with Pertuzumab therein and a package insert providing safety and/or efficacy data thereon; a method of making the article of manufacture; and a method of ensuring safe and effective use of Pertuzumab related thereto. In addition the application describes an intravenous (IV) bag containing a stable mixture of Pertuzumab and Trastuzumab suitable for administration to a cancer patient. |
申请公布号 |
IN2703CHN2014(A) |
申请公布日期 |
2015.07.03 |
申请号 |
IN2014CHENP2703 |
申请日期 |
2014.04.09 |
申请人 |
F. HOFFMANN LA ROCHE AG |
发明人 |
ALAVATTAM SREEDHARA;AMLER LUKAS C.;DE TOLEDO PELIZON CHRISTINA H.;BENYUNES MARK C.;CLARK EMMA L.;KWONG GLOVER ZEPHANIA W.;MITCHELL LADA;RATNAYAKE JAYANTHA;ROSS GRAHAM A.;WALKER RU AMIR |
分类号 |
A61K39/395;A61K45/06;C07K16/32 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|